ClinicalTrials.gov
ClinicalTrials.gov Menu

Long Term Cardiovascular Complications in Men With Obstructive Sleep Apnea

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01475682
Recruitment Status : Unknown
Verified July 2014 by Lam Jamie Chung Mei, The University of Hong Kong.
Recruitment status was:  Recruiting
First Posted : November 21, 2011
Last Update Posted : July 17, 2014
Sponsor:
Information provided by (Responsible Party):
Lam Jamie Chung Mei, The University of Hong Kong

Brief Summary:
Subjects with Obstructive Sleep Apnea (OSA) are at increased risk of developing cardiometabolic complications, and effective long-term nCPAP treatment significantly reduces the risk of cardiovascular morbidity and mortality.

Condition or disease
Obstructive Sleep Apnea Cardiovascular Diseases Metabolic Diseases

Detailed Description:
  1. Primary outcome:

    Incidence of cardiometabolic diseases in subjects with OSA over 9 years.

  2. Secondary outcomes:

Effects of CPAP treatment on cardiometabolic conditions


Study Type : Observational
Estimated Enrollment : 167 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Long Term Cardiovascular Complications in Men With Obstructive Sleep Apnea - Prospective 9 Years Follow-up Study
Study Start Date : November 2011
Estimated Primary Completion Date : May 2015
Estimated Study Completion Date : May 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sleep Apnea

Group/Cohort
1
167 subjects recruited from our previous "OSA and metabolic syndrome" (OSAMS) cohort from October 2002 to June 2007 will be invited to be reassessed at this time point.



Primary Outcome Measures :
  1. Incidence of cardiometabolic complications [ Time Frame: 9 years ]
    167 subjects recruited from our previous "OSA and metabolic syndrome" (OSAMS) cohort from October 2002 to June 2007 will be invited to be reassessed at this time point.


Secondary Outcome Measures :
  1. Effects of CPAP treatment on cardiometabolic conditions [ Time Frame: 9 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
167 subjects recruited from our previous "OSA and metabolic syndrome" (OSAMS) cohort from October 2002 to June 2007 will be invited to be reassessed at this time point.
Criteria

Inclusion Criteria:

  • From previous cohort for reassessment.

Exclusion Criteria:

  • Unstable medical conditions

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01475682


Contacts
Contact: Jamie C Lam, MD 852-22555906 lamcmj@hku.hk

Locations
Hong Kong
Queen Mary Hospital Recruiting
Hong Kong, Hong Kong
Contact: Jamie C Lam, MD    852-22555906    lamcmj@hku.hk   
Sponsors and Collaborators
The University of Hong Kong
Investigators
Principal Investigator: Jamie C Lam, MD The University of Hong Kong

Responsible Party: Lam Jamie Chung Mei, Honorary Clinical Assistant Professor, The University of Hong Kong
ClinicalTrials.gov Identifier: NCT01475682     History of Changes
Other Study ID Numbers: UW 10-002
First Posted: November 21, 2011    Key Record Dates
Last Update Posted: July 17, 2014
Last Verified: July 2014

Keywords provided by Lam Jamie Chung Mei, The University of Hong Kong:
Obstructive sleep apnea
cardiometabolic complications
Effects of CPAP treatment

Additional relevant MeSH terms:
Apnea
Cardiovascular Diseases
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Metabolic Diseases
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases